ATE421571T1 - Neues protein tab2 - Google Patents

Neues protein tab2

Info

Publication number
ATE421571T1
ATE421571T1 AT99974205T AT99974205T ATE421571T1 AT E421571 T1 ATE421571 T1 AT E421571T1 AT 99974205 T AT99974205 T AT 99974205T AT 99974205 T AT99974205 T AT 99974205T AT E421571 T1 ATE421571 T1 AT E421571T1
Authority
AT
Austria
Prior art keywords
tab2
signal transduction
new protein
tak1
activation
Prior art date
Application number
AT99974205T
Other languages
English (en)
Inventor
Kunihiro Matsumoto
Original Assignee
Kunihiro Matsumoto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kunihiro Matsumoto filed Critical Kunihiro Matsumoto
Application granted granted Critical
Publication of ATE421571T1 publication Critical patent/ATE421571T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869Interleukin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/02Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/20Screening for compounds of potential therapeutic value cell-free systems

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT99974205T 1999-11-19 1999-11-19 Neues protein tab2 ATE421571T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1999/006466 WO2001038527A1 (fr) 1999-11-19 1999-11-19 Nouvelle proteine tab2

Publications (1)

Publication Number Publication Date
ATE421571T1 true ATE421571T1 (de) 2009-02-15

Family

ID=14237333

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99974205T ATE421571T1 (de) 1999-11-19 1999-11-19 Neues protein tab2

Country Status (6)

Country Link
US (3) US7153664B2 (de)
EP (1) EP1234880B9 (de)
JP (1) JP4488665B2 (de)
AT (1) ATE421571T1 (de)
DE (1) DE69940359D1 (de)
WO (1) WO2001038527A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1234880B9 (de) 1999-11-19 2009-09-23 Kunihiro Matsumoto Neues protein tab2
JPWO2004022599A1 (ja) * 2002-08-22 2005-12-22 株式会社ペプタイドドア 融合抗体及びその作成方法
GB0306071D0 (en) * 2003-03-17 2003-04-23 Novartis Ag Organic compounds
EP1608755B1 (de) * 2003-04-01 2012-10-17 Helmholtz-Zentrum für Infektionsforschung GmbH Tak1-vermittelte hemmung der osteogenese
US8765370B2 (en) * 2009-06-11 2014-07-01 Scinopharm Taiwan, Ltd Inhibition-based high-throughput screen strategy for cell clones
KR101595318B1 (ko) 2014-03-25 2016-02-18 한국알프스 주식회사 다채널 led 조명기구에서 채널간의 전류편차 최소화 제어방법
US9452213B2 (en) 2014-07-15 2016-09-27 Inventprise, Llc Genetically detoxified pertussis vaccine that maintains intrinsic adjuvant activity
CN110201418B (zh) * 2019-05-09 2020-10-27 西安交通大学 一种基于固定化SNAP-tag融合蛋白的细胞膜色谱柱及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837703A (en) * 1993-03-31 1998-11-17 Cell Therapeutics, Inc. Amino-alcohol substituted cyclic compounds
US5576423A (en) * 1994-12-02 1996-11-19 Schering Corporation Antibodies to the slam protein expressed on activated T cells
ES2230586T3 (es) * 1996-04-24 2005-05-01 Chugai Seiyaku Kabushiki Kaisha Proteina tab1 y asdn que la codifica.
JP3907247B2 (ja) 1996-04-24 2007-04-18 中外製薬株式会社 Tab1蛋白質及びそれをコードするdna
EP1234880B9 (de) 1999-11-19 2009-09-23 Kunihiro Matsumoto Neues protein tab2

Also Published As

Publication number Publication date
US7153664B2 (en) 2006-12-26
US20120064084A1 (en) 2012-03-15
US20030040050A1 (en) 2003-02-27
US8491900B2 (en) 2013-07-23
US8058241B2 (en) 2011-11-15
DE69940359D1 (de) 2009-03-12
EP1234880B9 (de) 2009-09-23
EP1234880A4 (de) 2004-03-31
WO2001038527A1 (fr) 2001-05-31
EP1234880B1 (de) 2009-01-21
JP4488665B2 (ja) 2010-06-23
EP1234880A1 (de) 2002-08-28
US20070161565A1 (en) 2007-07-12

Similar Documents

Publication Publication Date Title
DE69940359D1 (de) Neues protein tab2
DE69917469D1 (de) Pyrimidin derivate
BRPI0415433A (pt) derivados de n-[fenil (alquilpiperidin-2-il)metil] benzamida, seu preparo e sua aplicação em terapêutica
CA2230082A1 (en) Amide compounds and use thereof
WO1999067252A3 (en) Epothilone derivatives and their synthesis and use
PT1193270E (pt) Pirrolobenzodiazepinas
EP1288202A4 (de) N-acyltetrahydroisochinolin-derivate
ATE442364T1 (de) Kristalline form von linezolid
DK482088D0 (da) Anvendelse af 1,3,7-trisubstituerede purin-2,6-dion-forbindelser til fremstilling af et laegemiddel med interleukin-1-inhiberende virkning
NO20030885L (no) Inhibitorer av <alfa>4 styrt celleadhesjon
ES2061684T3 (es) Compuestos de benzoxazina y su uso farmaceutico.
DE60001077D1 (de) Kautschukmischungen mit einem niedrigen Elastizitätsmodul
BR0307071A (pt) ésteres hidroxamato do ácido n-(fenil 4-substituìdo)-antranìlico
SE9100920D0 (sv) New active compounds
DE59509982D1 (de) Befestigungselement zum Eintreiben in harte Aufnahmematerialien mittels pulverkraftbetriebener Setzgeräte
NO980522L (no) En-sats syntese av 2-oksazolidinonderivater
DE60141875D1 (de) Messung des Ähnlichkeitsgrads der Stimme
FR2796732B1 (fr) Piece d'horlogerie a affichage du quantieme
FR2820471B3 (fr) Perfectionnement apporte a la structure d'une vis
EP1632484A4 (de) Thiadiazolinderivat
DE69132707D1 (de) N-Acyldipeptide, und pharmazeutische Präparate davon
ATE137759T1 (de) S'-adenosyl-methionin-decarboxylase-inhibitoren
NO951533D0 (no) Piezoelektrisk element med regulerbar polarisasjon
DK0699678T3 (da) Krystallinsk form af dihydro-2,3-benzodiazepinderivat
FR2839173B1 (fr) Detecteur capacitif d'empreintes digitales

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties